MedTrace Logo

The Use of Magnesium to Improve Blood Pressure, Cholesterol, and Glucose Control

NCT00282659 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2019-05-21

No results posted yet for this study

Summary

The purpose of this study is to determine if magnesium can improve blood pressure, cholesterol, and blood sugar control in patients with implantable cardioverter defibrillators (ICDs).

Conditions

Interventions

DRUG

magnesium L-lactate

Sponsors & Collaborators

  • Hartford Hospital

    lead OTHER

Principal Investigators

  • Charles M White, PharmD · University of Connecticut School of Pharmacy, Hartford Hospital Division of Drug Information

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Primary Completion
2008-06-30
Completion
2008-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00282659 on ClinicalTrials.gov